Loading
No insider purchase over the last 90 days. The latest, by Flynn James E, was filed 28 Jan 2015.
This page follows insider dealings at Auspex Pharmaceuticals, Inc. as filed with SEC (Form 4). No insider at Auspex Pharmaceuticals, Inc. has published a filing in the past twelve months. The most recent one dates from 7 May 2015.
Over the whole record (from 2014), the tally stands at 19 purchases and 63 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
25 of 143 declarations
Auspex Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for neurological disorders. It is listed on NASDAQ under the ticker ASPX.